Sees FY26 revenue $400B, consensus $418.33B. Sees FY26 adjusted operating income $13.26B-$13.6B. Sees FY26 cash flow from operations at least $10B. “We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026,” said executive vice president and Chief Financial Officer, Brian Newman. “We are committed to doing what we say. Our guidance philosophy is centered on providing credible and clear expectations with opportunities for outperformance. Our long-term outlook highlights the power of our diversified enterprise in a constantly evolving industry.” At Investor Day, CVS Health (CVS) will provide 2026 full-year financial guidance.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Cantor Fitzgerald says CMS guidance reinforces 2026 as ‘difficult for Medicaid’
- Republican lawmakers have yet to agree on healthcare plan, WSJ reports
- CVS Health price target raised to $86 from $77 at Bernstein
- Tesla’s Crowd of Investors Starting to Thin Out, According to New Data
- Jakks Pacific announces new licensing partnership with The Hershey Company